FERI (Luxembourg) S.A.’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.24M Sell
35,860
-36,380
-50% -$2.3M 0.3% 75
2026
Q2
$4.16M Buy
72,240
+36,380
+101% +$2.09M 0.66% 40
2026
Q1
$2.17M Sell
35,860
-39,740
-53% -$2.32M 0.42% 66
2025
Q4
$4.08M Buy
75,600
+4,390
+6% +$211K 0.91% 33
2025
Q3
$3.21M Buy
71,210
+11,870
+20% +$554K 0.93% 33
2025
Q2
$2.75M Buy
+59,340
New +$2.91M 0.88% 36
2025
Q1
– Sell
-8,040
Closed -$455K – 98
2024
Q4
$455K Buy
+8,040
New +$449K 0.25% 96
2024
Q1
– Sell
-21,450
Closed -$1.1M – 113
2023
Q4
$1.1M Buy
+21,450
New +$1.13M 0.81% 46

Other funds holding BMY

FERI (Luxembourg) S.A.'s BMY Position: Q3 2026 in Review

FERI (Luxembourg) S.A. reduced its Bristol-Myers Squibb (BMY) stake by 50% in Q3 2026, selling an estimated $2.3M and leaving 35,860 shares worth $2.24M. The position accounts for 0.3% of the portfolio, ranked #75.

FERI (Luxembourg) S.A. first reported a position in BMY in Q4 2023 and has held it in 8 quarters since. The position peaked at $4.16M in Q2 2026. 2,416 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • FERI (Luxembourg) S.A. held 35,860 shares of Bristol-Myers Squibb worth $2.24M as of Q3 2026.
  • FERI (Luxembourg) S.A. sold 36,380 Bristol-Myers Squibb shares in Q3 2026, an estimated $2.3M.
  • Bristol-Myers Squibb made up 0.3% of FERI (Luxembourg) S.A.'s portfolio in Q3 2026, its #75 holding.
  • FERI (Luxembourg) S.A. first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 8 quarters since.
  • FERI (Luxembourg) S.A.'s Bristol-Myers Squibb position peaked at $4.16M in Q2 2026.
  • 2,416 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on FERI (Luxembourg) S.A.'s 13F filing for Q3 2026, filed 16 Nov 2026.